FDA’s Upcoming Drug/Diagnostic Co-Development Guidance Could Quickly Become Outdated
This article was originally published in The Gray Sheet
Executive Summary
Tests that look for many markers at a time “may completely change” the paradigm for companion diagnostics, CDRH’s Elizabeth Mansfield says.